A father’s gut microbes influence the infant microbiota

Maternal fecal microbiota transfer in babies born by caesarean section can help to correct alterations in microbiota composition.

Exploring the connection between the microbiome and musculoskeletal performance

Microbiomepost conducted an exclusive interview with Antonio Paoli, full professor of Sport and Exercise Sciences at University of Padua, in Italy, about how exercise interferes with gut microbiome.

Advancing One Health: Highlights from the International Human Microbiome Congress 2024

The microbiome is a key piece in the One Health puzzle given that microbes and antimicrobial resistance genes travel extensively between the different compartments, and effectively connects all healths.

Birth mode and location influence the infant gut microbiota

The findings of a recent study suggest that environmental factors are important for the development of a healthy microbiota.

The role of gut microbes in aging

Understanding how gut microbes influence biological processes related to aging may inform interventions aimed at optimizing the microbiota to promote longevity.

Flow-FISH: A Breakthrough in Probiotic Quality Control

A new method published in June 2024 represents a significant leap forward in the quality control of probiotic products.

Boosting poultry resilience with Bacillus subtilis DSM29784 metabolites

Microbiomepost conducted an exclusive interview with Nuria Vieco, Adisseo France S.A.S, European Laboratory of Innovation Science and Expertise ELISE, about the effect of Bacillus subtilis DSM29784 secreted metabolites on poultry…

Fiber-rich diet and specific gut microbes may alleviate alcohol-induced liver injury

The findings of a recent study suggest that combining dietary fiber with B. acidifaciens can be a therapeutic strategy for alcoholic liver disease.

Artificial intelligence reveals a treasure trove of antimicrobial molecules

The findings suggest that artificial intelligence can help uncover new antibiotics, opening the way for new approaches to antibiotic discovery. The work also offers an open-access resource for antibiotic developers.

Ancilia Biosciences secures $4.2 Million to boost CRISPR-based bacterial therapies

This funding aims to propel the development of bacterial products and therapies that are not only unique but immune to viruses, enhancing their therapeutic potential.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top